On-Demand Webcast

Share

Program Content

Activities

  • HER2+ MBC Novel Therapies
    Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 11, 2020

    Expires: September 10, 2021

Faculty

cover img faculity

Adam M. Brufsky, MD, PhD

Associate Professor
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh
Pittsburgh, Pennsylvania

cover img faculity

Thomas Bachelot, MD, PhD

Chair, Unicancer Breast Group - UCBG
Breast Cancer Unit
Medical Oncology
Centre Leon Bérard
Lyon, France

cover img faculity

Cristina Saura, MD, PhD

Medicine and Surgery/Medical Oncology
Universidad Universitat Autònoma Barcelona and Vall d’Hebron Institute of Oncology (VHIO)
Head, Breast Cancer Program
Medical Oncology
Vall d’Hebrón University Hospital
Barcelona, Spain

Provided by

ProCE Banner

Supporters

Daiichi Sankyo, Inc.